E2F2 suppresses Myc-induced proliferation and tumorigenesis

Molecular Carcinogenesis

Volumn 49, Issue 2, 2010, Pages 152-156

  Pusapati, Raju V ^a,b,d   Weaks, Regina L ^a   Rounbehler, Robert J ^a,e   McArthur, Mark J ^c   Johnson, David G ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

E2F; Myc; Oral squamous cell carcinoma

Indexed keywords

CYCLIN D; CYCLIN E; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MYC PROTEIN; PROTEIN P16; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER MODEL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CYCLIN E GENE; E2F2 GENE; EPIDERMIS; GENE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE REPRESSION; HEMIZYGOSITY; HUMAN; KERATINOCYTE; MOUSE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SKIN CANCER; TRANSGENE;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; E2F2 TRANSCRIPTION FACTOR; GENES, MYC; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 75849145229     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20584     Document Type: Article

References (24)

1. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997;94:7245-7250.
2. Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993;365:349-352.
3. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006;6:739-748.
4. Sears R, Ohtani K, Nevins JR. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol 1997; 17:5227-5235.
5. Leone G, Sears R, Huang E, et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell 2001;8: 105-113.
6. Murga M, Fernandez-Capetillo O, Field SJ, et al. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 2001;15:959-970.
7. Zhu JW, Field SJ, Gore L, et al. E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis. Mol Cell Biol 2001;21:8547-8564.
8. Infante A, Laresgoiti U, Fernandez-Rueda J, et al. E2F2 represses cell cycle regulators to maintain quiescence. Cell Cycle 2008;7:3915-3927.
9. Johnson DG, Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 2006;6:731-738.
10. Scheijen B, Bronk M, van der Meer T, De Jong D, Bernards R. High incidence of thymic epithelial tumors in E2F2 transgenic mice. J Biol Chem 2004;279:10476-10483.
11. Opavsky R, Tsai SY, Guimond M, et al. Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci USA 2007;104:15400-15405.
12. Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res 2002;62:3276-3281.
13. Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG. Myc lacks E2F1's ability to suppress skin carcinogenesis. Oncogene 2001;20:5341-5349.
14. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005;6:635-645.
15. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008;8:976-990.
16. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, Jonasson JG, Egilsson V, Ingvarsson S. Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival. Br J Cancer 1999;79:1468-1474.
17. Araki D, Uzawa K, Watanabe T, et al. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity. Int J Oncol 2002;20:355-360.
18. Lefeuvre M, Gunduz M, Nagatsuka H, et al. Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas. J Oral Pathol Med 2009;38:94-98.
19. Komuro H, Valentine MB, Rowe ST, et al. Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma. J Pediatr Surg 1998;33:1695-1698.
20. Chang TC, Yu D, Lee YS, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008;40:43-50.
21. Cowling VH, Cole MD. E-cadherin repression contributes to c-Myc-induced epithelial cell transformation. Oncogene 2007;26:3582-3586.
22. Ravitz MJ, Chen L, Lynch M, Schmidt EV. c-myc Repression of TSC2 contributes to control of translation initiation and Myc-inducedtransformation. Cancer Res 2007;67:11209-11217.
23. Kurland JF, Tansey WP. Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Res 2008;68:3624-3629.
24. Watson JD, Oster SK, Shago M, Khosravi F, Penn LZ. Identifying genes regulated in a Myc-dependent manner. J Biol Chem 2002;277:36921-36930.